Trials / Completed
CompletedNCT01496573
Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
Observational - CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 77 (actual)
- Sponsor
- Children's Oncology Group · Network
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This research trial studies biomarkers in tumor tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
Detailed description
PRIMARY OBJECTIVES: I. To demonstrate CRKL expression at the protein level in rhabdomyosarcoma tumors by tissue microarray (TMA). OUTLINE: Archived tumor tissue samples are analyzed for CRKL expression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | laboratory biomarker analysis | Correlative studies |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2011-12-21
- Last updated
- 2016-05-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01496573. Inclusion in this directory is not an endorsement.